SGYP

Synergy Pharmaceuticals, Inc Common Stock
SGYP

Delisted

SGYP was delisted on the 7th of March, 2019.

143 hedge funds and large institutions have $436M invested in Synergy Pharmaceuticals, Inc Common Stock in 2017 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 60 increasing their positions, 32 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
143
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2M
Puts
$7.67M
Net Calls
Net Calls Change

Top Buyers

1 +$4.86M
2 +$4.01M
3 +$3.88M
4
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$3.67M
5
Goldman Sachs
Goldman Sachs
New York
+$3.22M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$183K
77
$176K
78
$175K
79
$172K
80
$153K
81
$147K
82
$143K
83
$131K
84
$127K
85
$116K
86
$111K
87
$103K
88
$102K
89
$99K
90
$99K
91
$95K
92
$86K
93
$84K
94
$84K
95
$81K
96
$80K
97
$79.2K
98
$73K
99
$73K
100
$68K